The relationship between smoking, ethnicity and bladder cancer is complex and multifaceted, with substantial public and personal health as well as clinical implications. New evidence supports that targeted smoking cessation efforts among high-risk populations could reduce the burden of bladder cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development and preliminary validation of a PROS scale for Chinese bladder cancer patients with abdominal stoma
Scientific Reports Open Access 25 January 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Teoh, J. Y.-C. et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur. Urol. 78, 893–906 (2020).
Winters, B. R. et al. Does the diagnosis of bladder cancer lead to higher rates of smoking cessation? Findings from the Medicare Health Outcomes Survey. J. Urol. 202, 241–246 (2019).
Sell, V. et al. Awareness of smoking as a risk factor in bladder cancer: results from the prospective FinnBladder 9 trial. Eur. Urol. Focus 8, 1246–1252 (2022).
Mithani, M. H. et al. Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: a prospective survey. J. Pak. Med. Assoc. 68, 55–58 (2018).
Shariat, S. F., Catto, J. W., Klatte, T., Giannarini, G. & Briganti, A. There are cooler ways to die than smoking: urologists of the world, unite against this health care tragedy. Eur. Urol. Focus 1, 1–2 (2015).
Chierigo, F. et al. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity. Int. Urol. Nephrol. 54, 1521–1527 (2022).
Murphy, S. E. Nicotine metabolism and smoking: ethnic differences in the role of P450 2A6. Chem. Res. Toxicol. 30, 410–419 (2017).
Ward, E. et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J. Clin. 54, 78–93 (2004).
Liu, Y., Zhao, Y. C., Lu, Y., Goodarz, D. & Gershman, B. The role of smoking in explaining racial/ethnic disparities in bladder cancer incidence in the United States. Urol. Oncol. https://doi.org/10.1016/j.urolonc.2023.01.025 (2023).
Davis, D. R., Krishnan-Sarin, S. & Mazure, C. M. Considerations of sex and gender in FDA tobacco regulation. JAMA https://doi.org/10.1001/jama.2023.6803 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Laukhtina, E., Shariat, S.F. Smoking, ethnicity and bladder cancer — implications for public health and clinical practice. Nat Rev Urol 20, 643–644 (2023). https://doi.org/10.1038/s41585-023-00804-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-023-00804-4
